D&D Pharmatech Inc. (KOSDAQ: 347850)
South Korea
· Delayed Price · Currency is KRW 33,700
+100 (0.30%)
Sep 11, 2024, 9:00 AM KST
D&D Pharmatech Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Revenue | 13,242 | 18,677 | 610.57 | 1,364 | - | - | Upgrade
|
| Revenue Growth (YoY) | 2068.84% | 2958.97% | -55.24% | - | - | - | Upgrade
|
| Cost of Revenue | 16.49 | 21.35 | 31.36 | 26.09 | 43.06 | 13.92 | Upgrade
|
| Gross Profit | 13,226 | 18,656 | 579.21 | 1,338 | -43.06 | -13.92 | Upgrade
|
| Selling, General & Admin | 7,211 | 8,427 | 9,287 | 8,823 | 7,353 | 4,010 | Upgrade
|
| Research & Development | 16,790 | 19,973 | 47,125 | 56,826 | 50,805 | 19,550 | Upgrade
|
| Other Operating Expenses | 394.24 | 336.28 | 266.34 | 304.96 | 211.49 | 17.01 | Upgrade
|
| Operating Expenses | 28,382 | 32,142 | 69,232 | 77,015 | 69,064 | 31,119 | Upgrade
|
| Operating Income | -15,156 | -13,486 | -68,653 | -75,677 | -69,107 | -31,133 | Upgrade
|
| Interest Expense | -599.06 | -1,427 | -2,959 | -1,012 | -5,712 | -13,773 | Upgrade
|
| Interest & Investment Income | 784.73 | 570.24 | 729.08 | 259.37 | 806.81 | 877.39 | Upgrade
|
| Earnings From Equity Investments | -2,551 | -1,787 | -9,148 | - | - | 14,414 | Upgrade
|
| Currency Exchange Gain (Loss) | 189.17 | 405.96 | -670.81 | 244.8 | 171.16 | -176.3 | Upgrade
|
| Other Non Operating Income (Expenses) | 945.61 | 15,721 | 15,387 | 4,137 | 6,824 | -24,547 | Upgrade
|
| EBT Excluding Unusual Items | -16,387 | -2.21 | -65,315 | -72,047 | -67,017 | -54,338 | Upgrade
|
| Impairment of Goodwill | - | - | -27,421 | - | -494.42 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | - | 45,993 | Upgrade
|
| Gain (Loss) on Sale of Assets | -108.51 | -84.94 | 21,524 | - | - | -35.85 | Upgrade
|
| Asset Writedown | 4,582 | 4,582 | -92,301 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | 515.65 | - | Upgrade
|
| Pretax Income | -11,914 | 4,494 | -163,513 | -72,047 | -66,995 | -8,381 | Upgrade
|
| Income Tax Expense | -863.59 | 1,068 | -26,487 | -2,185 | -2,711 | -1,961 | Upgrade
|
| Earnings From Continuing Operations | -11,051 | 3,427 | -137,025 | -69,862 | -64,284 | -6,421 | Upgrade
|
| Minority Interest in Earnings | 502.66 | 507.26 | 958.94 | 1,638 | 878.08 | 61.5 | Upgrade
|
| Net Income | -10,548 | 3,934 | -136,067 | -68,224 | -63,406 | -6,359 | Upgrade
|
| Net Income to Common | -10,548 | 3,934 | -136,067 | -68,224 | -63,406 | -6,359 | Upgrade
|
| Shares Outstanding (Basic) | 10 | 9 | 8 | 8 | 7 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 10 | 9 | 8 | 8 | 7 | 3 | Upgrade
|
| Shares Change (YoY) | 18.02% | 16.38% | -2.05% | 12.66% | 118.38% | 33.79% | Upgrade
|
| EPS (Basic) | -1108.81 | 441.46 | -16881.58 | -8483.33 | -9097.20 | -1901.18 | Upgrade
|
| EPS (Diluted) | -2610.62 | -1103.63 | -16882.00 | -8694.64 | -9399.94 | -1901.18 | Upgrade
|
| Free Cash Flow | -12,678 | -9,163 | -53,795 | -53,560 | -51,176 | -23,543 | Upgrade
|
| Free Cash Flow Per Share | -1332.68 | -976.77 | -6674.28 | -6508.66 | -7006.11 | -7038.60 | Upgrade
|
| Gross Margin | 99.88% | 99.89% | 94.86% | 98.09% | - | - | Upgrade
|
| Operating Margin | -114.45% | -72.21% | -11244.15% | -5547.71% | - | - | Upgrade
|
| Profit Margin | -79.65% | 21.06% | -22285.31% | -5001.38% | - | - | Upgrade
|
| Free Cash Flow Margin | -95.74% | -49.06% | -8810.69% | -3926.36% | - | - | Upgrade
|
| EBITDA | -10,252 | -9,058 | -54,914 | -63,776 | -57,764 | -23,274 | Upgrade
|
| EBITDA Margin | -77.42% | -48.50% | - | - | - | - | Upgrade
|
| D&A For EBITDA | 4,905 | 4,428 | 13,739 | 11,901 | 11,343 | 7,859 | Upgrade
|
| EBIT | -15,156 | -13,486 | -68,653 | -75,677 | -69,107 | -31,133 | Upgrade
|
| EBIT Margin | -114.45% | -72.21% | - | - | - | - | Upgrade
|
| Effective Tax Rate | - | 23.76% | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.